Search

Search Constraints

You searched for: Author/Creator Yang, S

Search Results

6. 476OA phase I study to evaluate safety and efficacy of BPI-7711 in EGFRm+/T790M+ advanced or recurrent NSCLC patients. (24th November 2019)

7. 874PTreatment-free interval (TFI) following discontinuation of first-line nivolumab plus ipilimumab (N+I) or sunitinib (S) in patients (Pts) with advanced renal cell carcinoma (aRCC): CheckMate 214 analysis. (23rd October 2018)

8. A comparison between short GRB afterglows and kilonova AT2017gfo: shedding light on kilonovae properties. Issue 3 (19th February 2020)